Le Lézard
Classified in: Health
Subject: MRR

China Artificial Organs Market Research Report 2023: Organ Type, Technology, Material Type, Region, Competition, Forecast & Opportunities to 2028


DUBLIN, Nov. 28, 2023 /PRNewswire/ -- The "China Artificial Organs Market by Organ Type, Technology, Material Type, Region, Competition, Forecast & Opportunities, 2028" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

The China artificial organs market is expected to witness an impressive growth rate during the forecast period, 2024-2028.

The increasing pool of patients waiting for organ transplants, along with the rise in acceptance of organ transplants, are expected to bolster the growth of the market. Also, the growing occurrences of chronic diseases, such as cardiovascular diseases, chronic kidney diseases, and others, are propelling the growth of the market.

In 2021, China has over 10 million patients suffering from heart failure, with many requiring heart transplant surgeries. Also, the increasing geriatric population, which is highly prone to organ failure, is propelling the demand for artificial organs, which, in turn, is strengthening the growth of the market. According to the report of the Seventh National Census in China, in 2020, the proportion of people aged 65 and over in the total population was 13.5%.

The frequent incidences of road accidents and injuries leading to amputations are also increasing the demand for artificial organs. Additionally, increasing awareness about artificial organs among the population is also contributing to the market's growth.

Technological Advancements

The rise in the adoption of advanced tools and techniques in the medical as well as healthcare sector is expected to bolster the growth of the China artificial organs market in the upcoming years. The advent of the latest technologies, such as the development of new artificial organs based on electrophysical and optical technologies and 3D printing of biomaterials, among others, are projected to facilitate the growth of the artificial organ market in the country.

In 2021, CH Biomedical in Suzhou, and East China's Jiangsu Province, developed the first domestic magnetically levitated artificial heart. The device uses the same principle which is used to run high-speed maglev trains. This artificial heart increases the pumping power of the patient's failing heart, allowing it to deliver oxygen-rich blood throughout the body.

Increasing Occurrences of Organ Failures

An increase in the number of cases suffering from organ failure in the country is projected to strengthen the growth of the market. According to a study, around 1 to 1.5 million people in China requires organ transplant every year. This is attributed to the increasing incidences of chronic diseases.

Chronic diseases are often caused due to the changing lifestyle and rising consumption of unhealthy foods and alcohol, among others, thereby impelling the growth of the market. For instance, the major cause of kidney failure is diabetes and hypertension, due to which there is an increase in demand for kidney transplantation. In 2019, around 47,382 Chinese patients were waiting for kidney transplantation.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present China artificial organs market

Report Scope

China Artificial Organs Market, By Organ Type:

China Artificial Organs Market, By Technology:

China Artificial Organs Market, By Material Type:

China Artificial Organs Market, By Region:

For more information about this report visit https://www.researchandmarkets.com/r/t8sgz8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

at 20:05
Toyoda Gosei Co., Ltd.(TOKYO:7282), in its efforts to pioneer new businesses to resolve societal healthcare issues, has invested1 in Craif, Inc., a startup out of Nagoya University that develops urine test kits that enhance the possibility of the...

at 20:00
The "Janus Kinase (JAK) Inhibitors Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest research on the global Janus Kinase (JAK) inhibitors market underscores a substantial growth trajectory, with an...

at 19:50
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released March 4, 2024. The...

at 19:45
Blue Shield of California has received the 2024 World's Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical business practices....

at 18:35
AIDS Healthcare Foundation (AHF) urges the World Health Organization (WHO) to call on manufacturers of vital point-of-care (POC) CD4 equipment, including Abbott Laboratories and Becton Dickinson (BD), to continue production of the HIV testing...

at 18:30
Philip Morris International, the world's largest publicly traded cigarette company, plans to open a new cigarette factory in Tanzania, according to media reports. The announcement is yet another act of hypocrisy from the tobacco giant that claims it...



News published on and distributed by: